Vanda Pharmaceuticals Inc.
VNDA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001347178
No open-market purchases or sales by Vanda Pharmaceuticals Inc. insiders were filed in the last 90 days; 172 institutions reported holding it in 13F filings for Q2 2026, worth $304.1M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Vanda Pharmaceuticals Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 198
- +16 vs. Q3 2021
- Shares held
- 54.3M
- −975.5K (−1.8%) vs. Q3 2021
- Total value
- $851.4M
- −$95.5M (−10.1%) vs. Q3 2021
- New holders
- 39
- 65 more added
- Sold out
- 23
- 67 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VNDA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 172 | $304.1M |
| Q1 2026 | 171 | $319.4M |
| Q4 2025 | 153 | $369.4M |
| Q3 2025 | 150 | $224.0M |
| Q2 2025 | 140 | $212.4M |
| Q1 2025 | 146 | $202.1M |
| Q4 2024 | 146 | $206.7M |
| Q3 2024 | 152 | $206.3M |
| Q2 2024 | 148 | $246.0M |
| Q1 2024 | 144 | $198.0M |
| Q4 2023 | 157 | $213.8M |
| Q3 2023 | 180 | $227.2M |
| Q2 2023 | 188 | $370.7M |
| Q1 2023 | 178 | $395.9M |
| Q4 2022 | 190 | $410.0M |
| Q3 2022 | 178 | $544.1M |
| Q2 2022 | 174 | $610.6M |
| Q1 2022 | 188 | $636.7M |
| Q4 2021 | 198 | $851.4M |
| Q3 2021 | 182 | $946.9M |
| Q2 2021 | 181 | $1.18B |
| Q1 2021 | 189 | $820.0M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Vanda Pharmaceuticals Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −87,493−100.0% | Sold out |
| Jackson Creek Investment Advisors LLC | 0 | $0 | 0.00% | −66,016−100.0% | Sold out |
| Skandinaviska Enskilda Banken AB (publ) | 0 | $0 | 0.00% | −45,280−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −39,634−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −39,200−100.0% | Sold out |
| AXA S.A. | 0 | $0 | 0.00% | −23,900−100.0% | Sold out |
| Sawgrass Asset Management LLC | 0 | $0 | 0.00% | −20,630−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −14,039−100.0% | Sold out |
| Grantham, Mayo, Van Otterloo & Co. LLC | 0 | $0 | 0.00% | −13,100−100.0% | Sold out |
| Eqis Capital Management, Inc. | 0 | $0 | 0.00% | −12,943−100.0% | Sold out |
| Cornerstone Investment Partners, LLC | 0 | $0 | 0.00% | −11,456−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −10,743−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Meeder Asset Management Inc | 0 | $0 | 0.00% | −4,435−100.0% | Sold out |
| Penserra Capital Management LLC | 0 | $0 | 0.00% | −1,275−100.0% | Sold out |
| Pacitti Group Inc. | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| Carroll Financial Associates, Inc. | 0 | $0 | 0.00% | −109−100.0% | Sold out |
| Leonteq Securities AG | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Liberty Wealth Management LLC | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| Kowal Investment Group, LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Sofos Investments, Inc. | 0 | $0 | 0.00% | −185−100.0% | Sold out |